Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT01348074

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01348074
Main results
  • Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial Journal of thrombosis and haemostasis : JTH, 2014-08 DOI, PubMed 24837794

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01348074. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist
Acronym
DOSIDO
Condition
Venous Thromboembolism
Condition
Heart Valve Disease
Condition
Surgery
Intervention (Drug)
Double dose
Lead sponsor
McMaster University (class: other)

Record details

Record id
cardio:ct-nct01348074
Content hash
fd0c3289f8e44ecd5c5651a23bfb2b8a5d8f3f39c0e2d6129eaa95c9f040e17f